Prosecution Insights
Prosecution Insights
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (33%) |
| §103 only | 1 (33%) |
| §102 only | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PUTTLITZ, KARL J | 1 | 69.1% | +18.4% |
| EVANS, ASHLEY ELIZABETH | 1 | 10.0% | +29.9% |
| STOCKTON, LAURA LYNNE | 1 | 75.0% | +33.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18290575 | METHODS AND MARKERS FOR DIAGNOSIS OF PARKINSON'S DISEASE | EVANS, ASHLEY ELIZABETH | 85d overdue |
| 19078822 | PROTEOLYSIS TARGETING CHIMERA (PROTAC) COMPOSITIONS USING UBIQUITIN CONJUGATING ENZYME LIGANDS | PUTTLITZ, KARL J | 67d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18290575 | METHODS AND MARKERS FOR DIAGNOSIS OF PARKINSON'S DISEASE | EVANS, ASHLEY ELIZABETH | 85d overdue |
| 17369032 | UBE2K MODULATORS AND METHODS FOR THEIR USE | STOCKTON, LAURA LYNNE | 73d overdue |
| 19078822 | PROTEOLYSIS TARGETING CHIMERA (PROTAC) COMPOSITIONS USING UBIQUITIN CONJUGATING ENZYME LIGANDS | PUTTLITZ, KARL J | 67d overdue |
| Art Unit | Apps |
|---|---|
| 1646 | 1 |
| 3687 | 1 |
| 1626 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19078822 | PROTEOLYSIS TARGETING CHIMERA (PROTAC) COMPOSITIONS USING UBIQUITIN CONJUGATING ENZYME LIGANDS | PUTTLITZ, KARL J | 1646 | §101 | Non-Final OA | 67d overdue | Pending | Mar 13, 2025 |
| 18290575 | METHODS AND MARKERS FOR DIAGNOSIS OF PARKINSON'S DISEASE | EVANS, ASHLEY ELIZABETH | 3687 | §103 | Non-Final OA | 85d overdue | Pending | Nov 14, 2023 |
| 17369032 | UBE2K MODULATORS AND METHODS FOR THEIR USE | STOCKTON, LAURA LYNNE | 1626 | §102 | Final Rejection | 73d overdue | Pending | Jul 07, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial